GH Research (FRA:1KA) Long-Term Debt: €0.00 Mil (As of Mar. 2026)


FRA:1KA GH Research PLC FRA:1KA
40 GF Score
Price €23.40
! 2 Warning Signs
View Full Analysis

What is GH Research Long-Term Debt?

GH Research FRA:1KA +1.74% 40 Long-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:1KA with a GF Score™ of 40/100. The stock has 2 warning signs investors should review.

GH Research's Long-Term Debt for the quarter that ended in Mar. 2026 was €0.00 Mil.

GH Research  (FRA:1KA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

GH Research Long-Term Debt Related Terms

GH Research Long-Term Debt Historical Data

* Premium members only.

The historical data trend for GH Research's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GH Research Long-Term Debt Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

GH Research Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:1KA
40GF Score
GH Research PLC FRA:1KA
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €0.00 Mil mean?
GH Research (FRA:1KA) has a Long-Term Debt of €0.00 Mil as of Mar. 2026.
Is GH Research's Long-Term Debt too high?
GH Research's current Long-Term Debt is €0.00 Mil. Overall, GH Research has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does GH Research's Long-Term Debt compare to ATAI and RAPP?
GH Research's Long-Term Debt of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. GH Research's current Long-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GH Research stock overvalued right now?
GH Research (FRA:1KA) has a current Long-Term Debt of €0.00 Mil. The current Long-Term Debt is €0.00 Mil. GH Research's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For GH Research (FRA:1KA), the current Long-Term Debt is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GH Research Business Description

Other Exchanges GHRS:USA
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
40GF Score

Get the complete analysis for FRA:1KA

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.40
Price